Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapeutics save search
Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
VYGR | News | $7.57 0.93% 0.92% 320K
|
Health Technology
|
| O: 0.48%
H: 0.24%
C: -4.77%
SGMO | News | $0.5101 -0.27% 0.7% 0
|
Health Technology
|
| O: 3.13%
H: 0.38%
C: -2.68%
NBIX | News M | $133.66 1.26% 1.12% 7.8K
|
Health Technology
|
| O: -2.15%
H: 2.58%
C: 0.92%
candidate payment for collaboration program therapeutics milestone
Cullinan Therapeutics Announces Oversubscribed $280 million Private Placement
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
CGEM | $15.63 -0.19% -0.32% 850K
|
|
| O: 15.52%
H: 3.77%
C: -12.83%
MS | News 0 d | $92.09 1.58% 0.12% 2.9K
|
Finance
|
| O: 2.98%
H: 0.0%
C: 0.0%
million therapeutics
Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Kristian Humer as Chief Financial Officer
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
FHTX | $5.05 -4.72% -4.23% 0
|
Health Technology
|
| O: -14.72%
H: 0.08%
C: -2.74%
therapeutics financial
Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering
Published: 2024-04-15 (Crawled : 23:00) - biospace.com/
APVO | $0.71 -2.39% -3.77% 160K
|
Health Technology
|
| O: -4.09%
H: 4.5%
C: -3.39%
million offering therapeutics
Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published: 2024-04-15 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 0
|
Health Technology
|
| O: -1.75%
H: 0.85%
C: 0.85%
AZNCF | News | $138.73 1.86% -4.19% 0
|
Health Technology
|
| O: 2.1%
H: 0.0%
C: -2.52%
NVS | News | $95.12 0.81% 4.36% 160K
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
GSK | News | $40.59 2.11% 0.1% 1.3K
|
Health Technology
|
| O: -1.19%
H: 0.52%
C: -0.17%
BAX | $40.4 2.36% 0.0% 2.7M
|
Health Technology
|
| O: -0.1%
H: 0.13%
C: -1.08%
ABBV | News | $167.89 0.89% 0.51% 3.6M
|
Health Technology
|
| O: 0.32%
H: 0.96%
C: 0.22%
SNY | News | $47.15 1.84% 1.75% 11K
|
Health Technology
|
| O: -2.13%
H: 0.0%
C: 0.0%
BMRN | $89.49 0.97% 0.99% 0
|
Health Technology
|
| O: -0.72%
H: 0.0%
C: 0.0%
AZN | News | $70.13 2.31% 2.24% 11K
|
Health Technology
|
| O: -0.64%
H: 0.45%
C: -0.04%
AMGN | News | $271.91 1.11% 1.12% 560
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
set therapeutics market
Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Published: 2024-04-15 (Crawled : 21:00) - globenewswire.com
ALRN | $4.75 0.21% 1.25% 110K
|
Health Technology
|
| O: -9.95%
H: 3.18%
C: 0.19%
business year update therapeutics financial results
Zevra Therapeutics Presents New Data on the Long-Term Safety and Efficacy of Arimoclomol as a Treatment for Niemann-Pick Disease Type C at the SIMD 45th Annual Meeting
Published: 2024-04-15 (Crawled : 21:00) - globenewswire.com
ZVRA | $4.57 1.11% 1.09% 110K
|
n/a
|
| O: 1.15%
H: 1.03%
C: -1.45%
disease treatment for meeting therapeutics
Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million
Published: 2024-04-15 (Crawled : 20:00) - globenewswire.com
OTLK | News P | $8.09 -0.98% -1.24% 410
|
Health Technology
|
| O: -0.93%
H: 5.85%
C: 2.46%
therapeutics million
CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors
Published: 2024-04-15 (Crawled : 20:00) - globenewswire.com
CRGX | $19.03 -0.83% -0.68% 20
|
|
| O: -1.76%
H: 6.0%
C: 2.35%
LLY | News | $731.33 0.69% 0.73% 12K
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: 0.0%
BDTX | $5.02 -4.56% -4.78% 500K
|
Health Technology
|
| O: 0.57%
H: 2.86%
C: 2.48%
AUTL | $4.56 0.89% 1.31% 1.1M
|
Health Technology
|
| O: 0.0%
H: 2.04%
C: -0.82%
therapeutics
TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
Published: 2024-04-15 (Crawled : 13:00) - globenewswire.com
RNAZ | $0.459 -5.36% -6.69% 4.4K
|
Professional, Scientific, and T...
|
| O: 0.11%
H: 5.95%
C: -13.78%
mc138 fda ttx-mc138 tumors clearance trial therapeutics advanced
TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
Published: 2024-04-15 (Crawled : 12:00) - globenewswire.com
TGTX | $14.1 2.32% 2.41% 2.3M
|
Health Technology
|
| O: -3.94%
H: 3.0%
C: -0.57%
briumvi neurology presentation sclerosis for meeting therapeutics
Viracta Therapeutics Announces Positive Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial in Patients with Relapsed or Refractory Epstein-Barr Virus-Positive (EBV+) Peripheral T-Cell Lymphoma
Published: 2024-04-15 (Crawled : 12:00) - globenewswire.com
VIRX | $0.88 2.72% -3.3% 14K
|
Manufacturing
|
| O: -12.71%
H: 0.97%
C: -24.27%
t-cell positive topline trial therapeutics results
Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography (ERG) Data at ARVO 2024
Published: 2024-04-15 (Crawled : 12:00) - globenewswire.com
AKTX | $1.18 1.18% 2.82% 14K
|
Health Technology
|
| O: -3.15%
H: 3.24%
C: -2.44%
pre-clinical therapeutics
Axsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual Meeting
Published: 2024-04-15 (Crawled : 11:00) - globenewswire.com
AXSM | $71.1 4.71% 4.58% 200
|
Health Technology
|
| O: -3.37%
H: 0.83%
C: -0.76%
neurology meeting therapeutics
Gastrointestinal Therapeutics and Diagnostics: Propelling Global Markets with Cutting-Edge Technologies by BCC Research LLC
Published: 2024-04-15 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 0
|
Health Technology
|
| O: -0.53%
H: 0.61%
C: 0.61%
JNJ | News | $149.12 0.82% 0.59% 440K
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ABBV | News | $167.89 0.89% 0.51% 3.6M
|
Health Technology
|
| O: 0.13%
H: 0.11%
C: -1.73%
SNY | News | $47.15 1.84% 1.75% 11K
|
Health Technology
|
| O: 1.95%
H: 0.0%
C: 0.0%
research global gastrointestinal therapeutics
Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study
Published: 2024-04-15 (Crawled : 11:00) - globenewswire.com
NMRA | $10.41 2.26% 2.3% 59
|
|
| O: -20.17%
H: 11.46%
C: 0.99%
nmra-266 therapeutics study
Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer
Published: 2024-04-15 (Crawled : 11:00) - globenewswire.com
APLT | $4.41 0.69% 0.68% 1.1M
|
Health Technology
|
| O: -0.19%
H: 1.15%
C: -2.69%
commercial therapeutics
DIGITAL THERAPEUTICS STARTUP RESPIREE™ ANNOUNCES INCORPORATION IN US WITH RESIDENCY AT JLABS @ SAN FRANCISCO
Published: 2024-04-15 (Crawled : 07:00) - prnewswire.com
JNJ | News | $149.12 0.82% 0.59% 440K
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
therapeutics
Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology
Published: 2024-04-12 (Crawled : 20:00) - globenewswire.com
AQST | $4.38 6.7% 6.39% 22K
|
Health Technology
| Email alert
Add to watchlist
neurology for meeting therapeutics study
Compass Therapeutics Announces Poster Presentations at the Cholangiocarcinoma Foundation 2024 Annual Conference
Published: 2024-04-12 (Crawled : 12:00) - globenewswire.com
CMPX | $1.49 1.36% 0.0% 1
|
Professional, Scientific, and T...
|
| O: -4.19%
H: 9.38%
C: 1.25%
conference therapeutics foundation
Gainers vs Losers
| 72% | 28% |
Top 10 Gainers
AGBA | $2.5 100.0% 58.33% 200M
|
Finance
EDBL | News | $6.26 66.49% 48.56% 270K
|
SMFL | $4.35 29.2% 47.55% 4.2M
|
Manufacturing
MLEC | $2.47 76.43% 38.05% 460K
|
n/a
PEGY | $0.0458 -10.2% 28.77% 79M
|
Manufacturing
PROK | $2.72 33.33% 26.88% 20K
|
PALI | $4.93 4.67% 25.83% 2.1M
|
Manufacturing
SGD | $0.685 -1.71% 22.48% 2M
|
n/a
SILO | $1.99 0.71% 20.64% 1.8M
|
Finance and Insurance
NNVC | $1.12 1.82% 19.64% 2.5K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.